Related references
Note: Only part of the references are listed.Using 3 TLR ligands as a combination adjuvant induces qualitative changes in T cell responses needed for antiviral protection in mice
Qing Zhu et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
The Potential of Polyphosphazenes for Delivery of Vaccine Antigens and Immunotherapeutic Agents
Nelson Eng et al.
Current Drug Delivery (2010)
Approaches to enhancing immune responses stimulated by CpG oligodeoxynucleotides
George Mutwiri et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists
Joerg Vollmer et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
Enhancement of the priming efficacy of DNA vaccines encoding dendritic cell-targeted antigens by synergistic toll-like receptor ligands
Claudius Grossmann et al.
BMC IMMUNOLOGY (2009)
Current status and progress of prepandemic and pandemic influenza vaccine development
Isabel Leroux-Roels et al.
EXPERT REVIEW OF VACCINES (2009)
Formulation of bovine respiratory syncytial virus fusion protein with CpG oligodeoxynucleotide, cationic host defence peptide and polyphosphazene enhances humoral and cellular responses and induces a protective type 1 immune response in mice
J. Kovacs-Nolan et al.
JOURNAL OF GENERAL VIROLOGY (2009)
AS04, an Aluminum Salt- and TLR4 Agonist-Based Adjuvant System, Induces a Transient Localized Innate Immune Response Leading to Enhanced Adaptive Immunity
Arnaud M. Didierlaurent et al.
JOURNAL OF IMMUNOLOGY (2009)
Tuberculosis Subunit Vaccination Provides Long-Term Protective Immunity Characterized by Multifunctional CD4 Memory T Cells
Thomas Lindenstrom et al.
JOURNAL OF IMMUNOLOGY (2009)
Vaccine Adjuvants: Current Challenges and Future Approaches
Jennifer H. Wilson-Welder et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome
Fiona A. Sharp et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
IC31®, a Two-Component Novel Adjuvant Mixed with a Conjugate Vaccine Enhances Protective Immunity against Pneumococcal Disease in Neonatal Mice
T. A. Olafsdottir et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2009)
The novel adjuvant combination of CpG ODN, indolicidin and polyphosphazene induces potent antibody- and cell-mediated immune responses in mice
J. Kovacs-Nolan et al.
VACCINE (2009)
Vaccination with combination of Fit3L and RANTES in a DNA prime-protein boost regimen elicits strong cell-mediated immunity and antitumor effect
Shuxia Song et al.
VACCINE (2009)
CpG oligonucleotide, host defense peptide and polyphosphazene act synergistically, inducing long-lasting, balanced immune responses in cattle
J. Kovacs-Nolan et al.
VACCINE (2009)
A novel vaccine adjuvant comprised of a synthetic innate defence regulator peptide and CpG oligonucleotide links innate and adaptive immunity
Jason Kindrachuk et al.
VACCINE (2009)
Induction of protective immunity by vaccination against Chlamydia trachomatis using the major outer membrane protein adjuvanted with CpG oligodeoxynucleotide coupled to the nontoxic B subunit of cholera toxin
Chunmei Cheng et al.
VACCINE (2009)
Towards an understanding of the adjuvant action of aluminium
Philippa Marrack et al.
NATURE REVIEWS IMMUNOLOGY (2009)
The Nlrp3 inflammasome is critical for aluminium hydroxide-mediated IL-1β secretion but dispensable for adjuvant activity
Luigi Franchi et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells
Mirjam Kool et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Intranasal immunization of mice with a formal in-inactivated bovine respiratory syncytial virus vaccine co-formulated with CpG oligodeoxynucleotides and polyphosphazenes results in enhanced protection
John W. Mapletoft et al.
JOURNAL OF GENERAL VIROLOGY (2008)
Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants
Stephanie C. Eisenbarth et al.
NATURE (2008)
Adult-Like Anti-Mycobacterial T Cell and In Vivo Dendritic Cell Responses Following Neonatal Immunization with Ag85B-ESAT-6 in the IC31® Adjuvant
Arun T. Kamath et al.
PLOS ONE (2008)
Molecular and cellular signatures of human vaccine adjuvants
F. Mosca et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Co-administration of polyphosphazenes with CpG oligodeoxynucleotides strongly enhances immune responses in mice immunized with Hepatitis B virus surface antigen
George Mutwiri et al.
VACCINE (2008)
The novel adjuvant IC31® strongly improves influenza vaccine-specific cellular and humoral immune responses in young adult and aged mice
Karin Riedl et al.
VACCINE (2008)
Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice
Andreas Wack et al.
VACCINE (2008)
GlaxoSmithKline Adjuvant systems in vaccines: concepts, achievements and perspectives
Nathalie Garcon et al.
EXPERT REVIEW OF VACCINES (2007)
The combination of GM-CSF and IL-2 as local adjuvant shows synergy in enhancing peptide vaccines and provides long term tumor protection
Antoun Toubaji et al.
VACCINE (2007)
L-BLP25: A peptide vaccine strategy in non-small cell lung cancer
Randeep Sangha et al.
CLINICAL CANCER RESEARCH (2007)
Poly[di(sodium carboxylatoethylphenoxy)phosphazene] (PCEP) is a potent enhancer of mixed Th1/Th2 immune responses in mice immunized with influenza virus antigens
George Mutwiri et al.
VACCINE (2007)
MyD88-dependent and MyD88-independent pathways in synergy, priming, and tolerance between TLR agonists
Aranya Bagchi et al.
JOURNAL OF IMMUNOLOGY (2007)
Pre-clinical evaluation of new adjuvant formulations to improve the immunogenicity of the malaria vaccine RTS,S/AS02A
V. Ann Stewart et al.
VACCINE (2006)
Sequence requirements and an optimization strategy for short antimicrobial peptides
Kai Hilpert et al.
CHEMISTRY & BIOLOGY (2006)
Enhanced humoral and memory B cellular immunity using HPV16/18 L1 VLP vaccine formulated with the MPL/aluminium salt combination (AS04) compared to aluminium salt only
Sandra L. Giannini et al.
VACCINE (2006)
Protective immunity to tuberculosis with Ag85B-ESAT-6 in a synthetic cationic adjuvant system IC31
Else Marie Agger et al.
VACCINE (2006)
IC31, a novel adjuvant signaling via TLR9, induces potent cellular and humoral immune responses
Carola Schellack et al.
VACCINE (2006)
Mucosal immunization against hepatitis A: Antibody responses are enhanced by co-administration of synthetic oligodeoxynucleotides and a novel cationic lipid
Leslie Ann Mitchell et al.
VACCINE (2006)
A new intranasal influenza vaccine based on a novel polycationic lipid - ceramide carbamoyl-spermine (CCS) - I. Immunogenicity and efficacy studies in mice
Aviva Joseph et al.
VACCINE (2006)
Modulating the adjuvanticity of alum by co-administration of muramyl di-peptide (MDP) or Quil-A
SA Moschos et al.
VACCINE (2006)
Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity
T Querec et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Synthesis, properties, and biological activity of poly[di(sodium carboxylatoethylphenoxy)phosphazene]
AK Andrianov et al.
BIOMACROMOLECULES (2006)
Triggering TLR signaling in vaccination
D van Duin et al.
TRENDS IN IMMUNOLOGY (2006)
Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children:: single-blind extended follow-up of a randomised controlled trial
PL Alonso et al.
LANCET (2005)
Bovine toll-like receptor 9: A comparative analysis of molecular structure, function and expression
PJ Griebel et al.
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY (2005)
The Expression of toll-like receptors 3 and 7 in rheumatoid arthritis synovium is increased and costimulation of toll-like receptors 3, 4, and 7/8 results in synergistic cytokine production by dendritic cells
MF Roelofs et al.
ARTHRITIS AND RHEUMATISM (2005)
Alarmins: chemotactic activators of immune responses
JJ Oppenheim et al.
CURRENT OPINION IN IMMUNOLOGY (2005)
Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells
G Napolitani et al.
NATURE IMMUNOLOGY (2005)
Immunomodulatory activities of small host defense peptides
DME Bowdish et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes
JL Lemesre et al.
VACCINE (2005)
Comparative immunomodulatory properties of a chitosan-MDP adjuvant combination following intranasal or intramuscular immunisation
SA Moschos et al.
VACCINE (2005)
Formulation with CpG oligodeoxynucleotides prevents induction of pulmonary immunopathology following priming with formalin-inactivated or commercial killed bovine respiratory syncytial virus vaccine
M Oumouna et al.
JOURNAL OF VIROLOGY (2005)
Structural and DNA-binding studies on the bovine antimicrobial peptide, indolicidin: evidence for multiple conformations involved in binding to membranes and DNA
CH Hsu et al.
NUCLEIC ACIDS RESEARCH (2005)
A review of licensed viral vaccines, some of their safety concerns, and the advances in the development of investigational viral vaccines
DB Huang et al.
JOURNAL OF INFECTION (2004)
The artificial antimicrobial peptide KLKLLLLLKLK induces predominantly a TH2-type immune response to co-injected antigens
JH Fritz et al.
VACCINE (2004)
Safety and immunogenicity of CPG 7909 injection as an adjuvant to Fluarix influenza vaccine
CL Cooper et al.
VACCINE (2004)
Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4+ and CD8+ T cell responses in humans
ID Davis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Selective immune redirection in humans with ragweed allergy by injecting Amb a 1 linked to immunostimulatory DNA
FER Simons et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
CPG 7909, an immunostimulatory TLR9 agonist oligodeoxynucleotide, as adjuvant to Engerix-B® HBV vaccine in healthy adults:: A double-blind phase I/II study
CL Cooper et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2004)
Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children:: randomised controlled trial
PL Alonso et al.
LANCET (2004)
Interaction of dendritic cells with antigen-containing liposomes: effect of bilayer composition
C Foged et al.
VACCINE (2004)
Increased protection against pneumococcal disease by mucosal administration of conjugate vaccine plus interleukin-12
JM Lynch et al.
INFECTION AND IMMUNITY (2003)
A phase I study of the safety and immunogenicity of recombinant hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide adjuvant
SA Halperin et al.
VACCINE (2003)
Recent advances in veterinary vaccine adjuvants
M Singh et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2003)
Intranasal vaccination using interleukin-12 and cholera toxin subunit B as adjuvants to enhance mucosal and systemic immunity to human immunodeficiency virus type 1 glycoproteins
DI Abu et al.
JOURNAL OF VIROLOGY (2003)
Host recognition of bacterial muramyl dipeptide mediated through NOD2
N Inohara et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Mucosal immunization with Helicobacter, CpG DNA, and cholera toxin is protective
WW Jiang et al.
INFECTION AND IMMUNITY (2003)
Enhancement of immune responses by co-delivery of a CpG oligodeoxynucleotide and tetanus toxoid in biodegradable nanospheres
M Diwan et al.
JOURNAL OF CONTROLLED RELEASE (2002)
CpG-containing oligodeoxynucleotides, in combination with conventional adjuvants, enhance the magnitude and change the bias of the immune responses to a herpesvirus glycoprotein
XP Ioannou et al.
VACCINE (2002)
The immunogenicity and protective efficacy of bovine herpesvirus 1 glycoprotein D plus emulsigen arc increased by formulation with CpG oligodeoxynucleotides
XP Ioannou et al.
JOURNAL OF VIROLOGY (2002)
CpG-containing oligodeoxynucleotides augment and switch the immune responses of cattle to bovine herpesvirus-1 glycoprotein D
R Rankin et al.
VACCINE (2002)
A cathelicidin family of human antibacterial peptide LL-37 induces mast cell chemotaxis
F Niyonsaba et al.
IMMUNOLOGY (2002)
Evaluation of cholera vaccines formulated with toxin-coregulated pilin peptide plus polymer adjuvant in mice
JY Wu et al.
INFECTION AND IMMUNITY (2001)
LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells
D Yang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Liposome-mediated cytosolic delivery of macromolecules and its possible use in vaccine development
M Owais et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2000)
CpG DNA overcomes hyporesponsiveness to hepatitis B vaccine in orangutans
HL Davis et al.
VACCINE (2000)
CpG DNA induces stronger immune responses with less toxicity than other adjuvants
RD Weeratna et al.
VACCINE (2000)
Share Paper
